An insurer's reinsurance program offers useful insights into how healthy it is and its risk appetite.
It all looks odd and mysterious to average investors, as though the insurer is trying to pull wool over our eyes, when in fact it is trying to do exactly the opposite.
Very broadly, QBE has modestly increased its risk appetite, the proportion of insurance it bears itself. This also increases QBE's potential profits (and losses) as reinsurance is expensive.
It does this after foreshadowing a $1.5b loss on 28 December. My comments then: https://hotcopper.com.au/posts/49676360/single. and https://hotcopper.com.au/posts/49727187/single
Many anticipated a big share price downgrade on that news, even me.
Today's announcement shows QBE, regulators and reinsurers all comfortable with its exposures. We will soon see if insurance analysts feel the same.
Insurance may be dull work, yet i do like the diversification it offers my portfolio, provided I am rewarded for risk.
Ash
- Forums
- ASX - By Stock
- Ann: QBE finalises 2021 reinsurance program
QBE
qbe insurance group limited
Add to My Watchlist
0.31%
!
$22.60

An insurer's reinsurance program offers useful insights into how...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$22.60 |
Change
0.070(0.31%) |
Mkt cap ! $34.12B |
Open | High | Low | Value | Volume |
$22.85 | $22.85 | $22.50 | $58.33M | 2.573M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 442 | $22.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.62 | 85 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 442 | 22.550 |
1 | 44 | 22.500 |
1 | 1000 | 22.280 |
1 | 1000 | 22.220 |
1 | 339 | 22.210 |
Price($) | Vol. | No. |
---|---|---|
22.750 | 2000 | 1 |
22.770 | 1230 | 2 |
22.790 | 4200 | 1 |
22.830 | 2540 | 2 |
22.850 | 540 | 1 |
Last trade - 16.15pm 04/07/2025 (20 minute delay) ? |
Featured News
QBE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online